476 related articles for article (PubMed ID: 25885919)
1. Mechanisms involved in breast cancer liver metastasis.
Ma R; Feng Y; Lin S; Chen J; Lin H; Liang X; Zheng H; Cai X
J Transl Med; 2015 Feb; 13():64. PubMed ID: 25885919
[TBL] [Abstract][Full Text] [Related]
2. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
3. New insights into the mechanisms of organ-specific breast cancer metastasis.
Lorusso G; Rüegg C
Semin Cancer Biol; 2012 Jun; 22(3):226-33. PubMed ID: 22504658
[TBL] [Abstract][Full Text] [Related]
4. Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer.
Liu H; Li X; Li H; Feng L; Sun G; Sun G; Wu L; Hu Y; Liu L; Wang H
Biomed Pharmacother; 2022 May; 149():112824. PubMed ID: 35306430
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer liver metastasis: current and future treatment approaches.
Rashid NS; Grible JM; Clevenger CV; Harrell JC
Clin Exp Metastasis; 2021 Jun; 38(3):263-277. PubMed ID: 33675501
[TBL] [Abstract][Full Text] [Related]
6. Protein deregulation associated with breast cancer metastasis.
Chan KK; Matchett KB; McEnhill PM; Dakir el H; McMullin MF; El-Tanani Y; Patterson L; Faheem A; Rudland PS; McCarron PA; El-Tanani M
Cytokine Growth Factor Rev; 2015 Aug; 26(4):415-23. PubMed ID: 26088937
[TBL] [Abstract][Full Text] [Related]
7. Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.
Yousefi M; Nosrati R; Salmaninejad A; Dehghani S; Shahryari A; Saberi A
Cell Oncol (Dordr); 2018 Apr; 41(2):123-140. PubMed ID: 29568985
[TBL] [Abstract][Full Text] [Related]
8. Organotropism of breast cancer metastasis.
Lu X; Kang Y
J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):153-62. PubMed ID: 17566854
[TBL] [Abstract][Full Text] [Related]
9. Color-Coded Imaging of Breast Cancer Metastatic Niche Formation in Nude Mice.
Suetsugu A; Momiyama M; Hiroshima Y; Shimizu M; Saji S; Moriwaki H; Bouvet M; Hoffman RM
J Cell Biochem; 2015 Dec; 116(12):2730-4. PubMed ID: 25981355
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and potential prognostic factors of breast cancer patients with liver metastases].
Wang JY; Xu BH; Tian LJ; Wang Y
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):612-6. PubMed ID: 17236558
[TBL] [Abstract][Full Text] [Related]
11. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects.
Urooj T; Wasim B; Mushtaq S; Shah SNN; Shah M
Curr Cancer Drug Targets; 2020; 20(3):168-186. PubMed ID: 31858911
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer liver metastasis: Pathogenesis and clinical implications.
Liu C; Mohan SC; Wei J; Seki E; Liu M; Basho R; Giuliano AE; Zhao Y; Cui X
Front Oncol; 2022; 12():1043771. PubMed ID: 36387238
[TBL] [Abstract][Full Text] [Related]
13. Surgery for breast cancer liver metastases - factors determining results.
Treska V; Cerna M; Liska V; Treskova I; Narsanska A; Bruha J
Anticancer Res; 2014 Mar; 34(3):1281-6. PubMed ID: 24596373
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.
Xie HY; Shao ZM; Li DQ
Chin J Cancer; 2017 Mar; 36(1):36. PubMed ID: 28356139
[TBL] [Abstract][Full Text] [Related]
15. Repeat Hepatectomy for Breast Cancer Liver Metastases.
Ruiz A; Castro-Benitez C; Sebagh M; Giacchetti S; Castro-Santa E; Wicherts DA; van Hillegersberg R; Paule B; Castaing D; Morère JF; Adam R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1057-66. PubMed ID: 26259753
[TBL] [Abstract][Full Text] [Related]
16. Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches.
Brodt P
Clin Cancer Res; 2016 Dec; 22(24):5971-5982. PubMed ID: 27797969
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer metastasis.
Scully OJ; Bay BH; Yip G; Yu Y
Cancer Genomics Proteomics; 2012; 9(5):311-20. PubMed ID: 22990110
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
19. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton.
Jiang P; Enomoto A; Takahashi M
Cancer Lett; 2009 Nov; 284(2):122-30. PubMed ID: 19303207
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
Kimbung S; Johansson I; Danielsson A; Veerla S; Egyhazi Brage S; Frostvik Stolt M; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmström PO; Söderberg M; Walz TM; Fernö M; Hatschek T; Hedenfalk I;
Clin Cancer Res; 2016 Jan; 22(1):146-57. PubMed ID: 26276891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
